HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Elizabeth Belcher Michael Dusmet Simon Jordan George Ladas Eric Lim Peter Goldstraw Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Belcher, E. Articles by Goldstraw, P. Search for Related Content PubMed Articles by Belcher, E. Articles by Goldstraw, P. Related Collections Lung - other

J Thorac Cardiovasc Surg 2010;140:32-38
© 2010 The American Association for Thoracic Surgery

General Thoracic Surgery

A prospective, randomized trial comparing BioGlue and Vivostat for the control of alveolar air leak

Department of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom

Received for publication June 24, 2009; revisions received September 21, 2009; accepted for publication November 14, 2009.

^_* Address for reprints: Elizabeth Belcher, MRCP, FRCS, PhD, Department of Thoracic Surgery, Royal Brompton Hospital, Sydney St, London, SW3 6NP, UK. (Email: elizabeth.belcher{at}gstt.nhs.uk).

Objective: BioGlue (CryoLife, Europa Ltd, Surrey, UK) is effective in reducing alveolar air leak after pulmonary resection. However, concerns exist regarding the use of bovine-derived products. Vivostat (Vivostat A/S, Alleroed, Denmark) is an autologous fibrin sealant that confers certain advantages. It shows superior elastic properties, a faster absorption time, and the absence of risk of transmission of blood-borne diseases.

Methods: We conducted a randomized, single blind controlled study to compare BioGlue and Vivostat in the control of postoperative air leak. Primary endpoints were duration of air leak, time to intercostal drain removal, and length of hospital stay. Secondary endpoints related to postoperative complications.

Results: Between December 2005 and December 2007, 103 patients were randomized. The analysis included 102 patients; 67% were male. Median age was 56 ± 19 years. Indications for surgery were primary lung cancer in 41 patients (40%), secondary malignancy in 48 patients (47%), carcinoid in 6 patients (6%), and 7 patients underwent surgery for benign disease (7%). Bilobectomy was performed in 2 patients (2%), lobectomy in 41 patients (40%), lobectomy with lesser resection in 3 patients (3%), segmentectomy in 16 patients (16%), precision excision in 34 patients (33%), and 6 patients underwent other resections (6%). Median duration of air leak was 3 (0–32) days versus 2 (0–33) days for patients who received BioGlue and Vivostat, respectively (P = .677). Time to intercostal drain removal was 5 (1–32) days in the BioGlue group compared with 5 (1–34) days for the Vivostat group (P = .473). Median hospital stay was 8 (3–22) days versus 7 (2–29) days for the BioGlue and Vivostat groups, respectively (P = .382). There was no significant difference in the incidence of complications between the 2 groups (20 patients receiving BioGlue versus 19 patients receiving Vivostat, P = .839).

Conclusions: There were no significant differences in the 3 clinical outcome measures of duration of air leak, time to intercostal drain removal, and length of hospital stay in those patients receiving BioGlue or Vivostat. Given the inherent advantages of our institutional preference is to use Vivostat in the control of postoperative air leaks after pulmonary resection.

This article has been cited by other articles:

				G. Cardillo, F. Carleo, L. Carbone, A. R. De Massimi, A. Lococo, P. F. Santini, A. Janni, and A. Gonfiotti Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial Eur J Cardiothorac Surg, December 16, 2011; (2011) ezr083v1. [Abstract] [Full Text] [PDF]